Skip to content
HowShorted

Immunic, Inc. short interest in 2022

In 2022, Immunic, Inc.'s disclosed short interest ran from 4.47% of shares outstanding on 14 Jan 2022 to 18.01% on 30 Dec 2022, a change of +13.54 percentage points. The year's high was 18.31% on 15 Dec 2022 and its low 2.31% on 30 Sep 2022, averaging 7.35% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.25 days on 15 Dec 2022. Full history: Immunic, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Immunic, Inc. in 2022

2022 in figures

Start of year
4.47% (14 Jan 2022)
End of year
18.01% (30 Dec 2022)
Change
+13.54 pp
High
18.31% (15 Dec 2022)
Low
2.31% (30 Sep 2022)
Average
7.35%
Highest days to cover
11.25 (15 Dec 2022)
SEC filings marked
8

Every report in 2022

Immunic, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20224.47%2.32
31 Jan 20224.74%6.00
15 Feb 20225.39%3.65
28 Feb 20225.14%5.1210-K filed, results (8-K)
15 Mar 20226.04%6.35
31 Mar 20225.74%11.12
14 Apr 20225.43%9.45
29 Apr 20224.35%3.42
13 May 20224.06%3.6910-Q filed, results (8-K)
31 May 20225.09%4.92
15 Jun 20226.21%1.00
30 Jun 20223.67%2.02
15 Jul 20223.79%9.17
29 Jul 20223.45%10.11
15 Aug 20223.18%5.1110-Q filed, results (8-K)
31 Aug 20223.01%10.84
15 Sep 20222.92%10.79
30 Sep 20222.31%3.82
31 Oct 202217.97%1.10
15 Nov 202217.81%3.7710-Q filed, results (8-K)
30 Nov 202217.94%6.13
15 Dec 202218.31%11.25
30 Dec 202218.01%8.74

See also: Immunic, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.